COMMUNIQUÉS West-GlobeNewswire

International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18
25/04/2024
With Over $675,000 Raised, the Gala Benefits the Peter Boyle Research Fund and Celebrates Groundbreaking Myeloma Research, Education, Support, and Advocacy STUDIO CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- On [...]
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
25/04/2024
TORONTO and HAIFA, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company is pleased to announce that its [...]
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
25/04/2024
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and [...]
Aphaia Pharma Provides Enrollment and Protocol Update for Phase 2 Trial in Individuals with Obesity
25/04/2024
Enrollment has been completed for the first two cohorts evaluating a once-daily 12g dose of its oral glucose formulation (APHD-012) The company is expanding its trial protocol to further explore the contribution of [...]
Starton Therapeutics Announces Enrollment Completion for STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
25/04/2024
Phase 1b data in the first 50% of patients reflect the responses seen in animals and may suggest superiority in both safety and efficacy when compared to oral Revlimid ® Anticipate FDA alignment and guidance on Phase 2 [...]
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
25/04/2024
MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
25/04/2024
BOSTON, April 25, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]
Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
25/04/2024
Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion gene Approval based on [...]
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
25/04/2024
THE WOODLANDS, TX, April 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how [...]
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
25/04/2024
Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- [...]
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
25/04/2024
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 [...]
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
25/04/2024
LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
25/04/2024
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS [...]
American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada
25/04/2024
The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need. FORT MYERS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- American Oncology [...]
Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline
25/04/2024
Financing round led by Agent Capital, Bioluminescence, and Double Point Ventures, with participation from new investors MQB Partners and others Proceeds will advance Cerevance’s first-in-class pre-clinical and clinical [...]
Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination
25/04/2024
LUBLIN, Poland, April 25, 2024 (GLOBE NEWSWIRE) -- An inherent feature of oncology is personalization, i.e., conversion from the fit-to-all strategy based on applying the same chemotherapy regimens to all patients with [...]
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
25/04/2024
STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious [...]
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
25/04/2024
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of [...]
iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024
25/04/2024
LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”) , an online global marketplace that connects scientists requiring biospecimens for medical research with [...]

Pages